Innovax-ND-ILT Europos Sąjunga - olandų - EMA (European Medicines Agency)

innovax-nd-ilt

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunologicals voor aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Prevexxion RN Europos Sąjunga - olandų - EMA (European Medicines Agency)

prevexxion rn

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease (md) virus, serotype 1, strain rn1250 - immunologicals voor aves - kip - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus).

Prevexxion RN+HVT+IBD Europos Sąjunga - olandų - EMA (European Medicines Agency)

prevexxion rn+hvt+ibd

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - kip - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Ultifend ND IBD Europos Sąjunga - olandų - EMA (European Medicines Agency)

ultifend nd ibd

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologicals voor aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Fungitraxx 10 mg/ml orale oplossing voor siervogels Nyderlandai - olandų - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

fungitraxx 10 mg/ml orale oplossing voor siervogels

avimedical b.v. - itraconazol - vloeistof voor oraal gebruik - itraconazol 10 mg/ml, - itraconazole - kooivogels

A.Vogel Dormeasan druppels Nyderlandai - olandų - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

a.vogel dormeasan druppels

hopstrobulus, tinctuur (ethanol-water 65-35 v,v)(1 = 12-13) 460 mg/ml ; valeriaanwortel, tinctuur (ethanol-water 58-42 v,v)(1 = 10-11) 460 mg/ml - druppels voor oraal gebruik, oplossing - ethanol ; water, gezuiverd

A.Vogel Keeltabletten, zuigtabletten Nyderlandai - olandų - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

a.vogel keeltabletten, zuigtabletten

echinacea purpurea herba, tinctuur (ethanol-water 65-35 v,v) (1=12-13) 760,4 mg/stuk ; echinacea purpurea wortel, tinctuur (ethanol-water 65-35 v,v) (1=11-12) 40 mg/stuk ; salvia officinalis folium ethanolisch (68 pct. v/v) extract (1=17) 378,5 mg/stuk - zuigtablet

Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune) Europos Sąjunga - olandų - EMA (European Medicines Agency)

pandemic influenza vaccine h5n1 astrazeneca (previously pandemic influenza vaccine h5n1 medimmune)

astrazeneca ab - reassortant influenzavirus (verzwakt levend) van de volgende stam: a / vietnam / 1203/2004 (h5n1) - influenza, human - vaccins - profylaxe van influenza in een officieel verklaarde pandemische situatie bij kinderen en adolescenten van 12 maanden tot jonger dan 18 jaar. pandemische influenza vaccin tegen h5n1 astrazeneca moet worden gebruikt in overeenstemming met officiële richtlijnen.

Roundup® Dynamic Nyderlandai - olandų - myHealthbox

roundup® dynamic

bayer ag - waterige oplossing - 500 g/l glyfosaat

Roundup® + Nyderlandai - olandų - myHealthbox

roundup® +

bayer ag - waterige oplossing - 360 g/l glyfosaat